IN THE NEWS: Karmanos’ Erlene Seymour, M.D., on late stage Diffuse Large B-Cell Lymphoma treatment Options


Erlene Seymour, M.D., hematology oncologist at Karmanos Cancer Institute joined Patient Power Co-Founder Andrew Schorr to explain diagnosing advanced DLBCL, the standard therapy R-CHOP (rituximab, cyclophosphamide, hydroxydaunorubicin, oncovin and prednisone) and the new medications that are being used in combination with R-CHOP.